Development of expression vectors for Escherichia coli based on the pCR2 replicon
© Walia et al; licensee BioMed Central Ltd. 2007
Received: 13 March 2007
Accepted: 10 May 2007
Published: 10 May 2007
Recent developments in metabolic engineering and the need for expanded compatibility required for co-expression studies, underscore the importance of developing new plasmid vectors with properties such as stability and compatibility.
We utilized the pCR2 replicon of Corynebacterium renale, which harbours multiple plasmids, for constructing a range of expression vectors. Different antibiotic-resistance markers were introduced and the vectors were found to be 100% stable over a large number of generations in the absence of selection pressure. Compatibility of this plasmid was studied with different Escherichia coli plasmid replicons viz. pMB1 and p15A. It was observed that pCR2 was able to coexist with these E.coli plasmids for 60 generations in the absence of selection pressure. Soluble intracellular production was checked by expressing GFP under the lac promoter in an expression plasmid pCR2GFP. Also high level production of human IFNγ was obtained by cloning the h-IFNγ under a T7 promoter in the expression plasmid pCR2-IFNγ and using a dual plasmid heat shock system for expression. Repeated sub-culturing in the absence of selection pressure for six days did not lead to any fall in the production levels post induction, for both GFP and h-IFNγ, demonstrating that pCR2 is a useful plasmid in terms of stability and compatibility.
We have constructed a series of expression vectors based on the pCR2 replicon and demonstrated its high stability and sustained expression capacity, in the absence of selection pressure which will make it an efficient tool for metabolic engineering and co-expression studies, as well as for scale up of expression.
Using techniques of metabolic engineering E.coli has grown from a host used for the production of simple proteins, to a sophisticated platform which can be utilized to express complex proteins in their biologically active form and also complete metabolic pathways which require a calibrated and simultaneous expression of multiple genes. There is thus a need to develop and design versatile vectors for E.coli to serve as tools for the above purpose. Improvement of vectors are being carried out so that they can be used for special purposes, such as for the synthesis of proteins that can be easily recovered and purified , for directing the protein synthesized to specific compartments and thus facilitate proper folding  and also secretion to the extracellular medium . Many proteins need to be produced in large quantities, especially those that have commercial significance, like industrial enzymes or therapeutic proteins. In such cases issues of plasmid stability  are critical for getting sustained production during the scale up of cultures to industrial levels .
The use of two plasmid systems where the gene of interest is expressed by the first plasmid and the second plasmid contains genes which aid this expression, has found wide usage. Such a two plasmid system requires a set of vectors with different origins of replication, which are not only compatible but also able to co-exist stably over a large number of generations . Notable examples are expressing the T7 RNA polymerase gene in a second plasmid to drive the over-expression of the gene downstream of the T7 promoter , co-expression of different enzymes for pesticide degradation , the co-expression of chaperons like GroEL-GroES to help in the proper folding of the expressed protein , expression of genes involved in glycosylation  or other post translational modifications like tyrosine sulfation  in E.coli. The ability to clone and express all genes in a complete pathway, allows us to metabolically engineer cells to produce novel metabolites or enhance production levels of metabolites [12, 13]. These developments underscore the need to discover and construct new plasmid vectors, especially those that are compatible with other E.coli plasmids.
There are several reports describing the construction of novel and useful vectors with properties such as stability and compatibility with existing plasmids [14, 15]. However most of these reports do not demonstrate sustained expression abilities and long term co-existence, especially during high level production of recombinant proteins, when the cell is under a severe metabolic burden. To this end, we have used a new pCR2 replicon for the construction of expression vectors which have high level stability and sustained expression capability in the absence of selection pressure.
Results and discussion
Characterisation of pCR2 plasmid
Construction of pCR2amp and pCR2cat and stability studies
E.coli plasmid pET22b was taken as the source of the ampicillin cassette. Suitable primers were designed with Cla I restriction enzyme sites at both ends. The PCR amplicon of 1.1 kb was digested with Cla I and introduced into the Cla I site of pCR2 to get pCR2amp. The construct so obtained had a size of 4.3 kb. Similarly, the E.coli plasmid pACYC184 was taken as the source of the chloramphenicol cassette. Plasmid pACYC184 was digested with Acc I and BstB I, to release the complete chloramphenicol cassette of 1.1 kb and ligated to pCR2 digested with Cla I. The recombinant plasmid so obtained had a size of 4.3 kb and was designated as pCR2cat. The clones were confirmed by sequencing and used as a basic backbone for the construction of different expression vectors. As a first step, the stability of pCR2amp and pCR2cat was studied by repeated sub-culturing for six days, as described in materials and methods. Both the plasmids were found to be 100% stable for 60 generations demonstrating the extremely high level stability of this replicon in E. coli.
Compatibility studies of the pCR2 replicon with other E.coli plasmids
Even though many plasmid vectors exist in E.coli, these are mostly derived from the same parent plasmid and hence the range of distinct (and therefore compatible) origins is limited. Thus, most of the commonly used commercially available vectors have either pMB1(pUC, pET, pRSET series), p15A (pACYC184, pGP1-2) or ColE1 (pBacTag series) origins of replication. Of these, p15A based plasmids  are known to be unstable over a large number of generations in the absence of selection pressure.
Construction of pCR2 expression vector (pCR2-P lac -GFP) having P lac promoter and GFP as the reporter gene
Plasmid pNER41 containing a GFP reporter gene under the lac promoter was digested with Pst I and Nsi I to release a 2.2 kb fragment containing the GFP gene along with the lac promoter and a transcription terminator. This 2.2 kb fragment was ligated to pCR2amp digested with Nsi I resulting in the recombinant plasmid pCR2-P lac -GFP. The screening of positive clones was based on the fluorescence of transformed colonies under IPTG induction. The clones were further confirmed by restriction analysis and sequencing.
Shake flask studies on the stability of expression of pCR2-P lac -GFP in E.coli
Construction of a T7 promoter based pCR2 expression vector (pCR2-IFNγ)
The T7 expression system is routinely used for getting high-level production of recombinant proteins in E. coli. We chose a previously constructed recombinant clone pRSET-IFNγ  in which the human interferon gamma gene was cloned in the MCS of pRSET-A. Suitable primers were designed with Nsi I restriction sites at the ends, to amplify the complete expression cassette from the pRSET-IFNγ clone (consisting of the T7 promoter, the h-IFNγ gene in the MCS along with the transcriptional terminator). The PCR amplified fragment was digested with Nsi I and cloned at the Nsi I site of the pCR2amp plasmid. The resultant clones were confirmed by restriction analysis and PCR amplification (using the same gene specific primers), followed by sequencing. The vector so constructed was designated pCR2-IFNγ and had a size of 5 kb.
Expression studies with recombinant pCR2-IFNγ
To assess the long term compatibility of pCR2-IFNγ with another E.coli plasmid it was decided to try an alternate expression strategy where multiple copies of T7 RNA polymerase gene are present on a second plasmid (pGP1-2) under the heat inducible λPL promoter . E. coli DH5α was cotransformed with pCR2-IFNγ and pGP1-2 and the cells harboring the two plasmids were grown in the presence of ampicillin and kanamycin to mid exponential phase (OD600 – 0.4 to 0.6) at 30°C to repress expression. The culture was induced by heat shock at 42°C for 5 min and expression was checked post induction. From the SDS-PAGE it was clear that the IFNγ levels obtained by both expression systems i.e IPTG vs heat induction were nearly equal (Figure 7c). It is well known that T7 RNA polymerase production levels are higher in the dual plasmid system utilizing heat shock. However the fact that this did not lead to a correspondingly higher h-IFNγ in the heat induced system, demonstrates that the transcription step was not the rate limiting step in IFNγ expression. This is similar to earlier observations by researchers, who have shown that the rate limiting step in a T7 expression system is usually translation initiation .
This study conclusively demonstrated the stability and the sustained high level expression capacity of the pCR2-IFNγ construct, in the absence of selection pressure.
We have constructed expression vectors utilizing the pCR2 replicon and shown sustained expression of two model proteins viz GFP and IFNγ under different promoters. The pCR2 replicon is highly stable and compatible with a range of E.coli vectors. This property of pCR2 has potential commercial utility since it can be used for high level production of proteins in large scale fermenters, even in the absence of antibiotics.
Materials and methods
Bacterial strains and plasmids
E.coli DH5α and BL21 (DE3) strains were obtained from Novagen. Corynebacterium renale was grown at 37°C in Luria broth. E. coli plasmids pUC19 and pACYC184 were obtained from New England Biolabs. pET22b was obtained from Novagen. pRSET-IFNγ was constructed by cloning the h-IFNγ gene in a commercially available vector pRSETA . For this total RNA was isolated from H37RV induced human PBMCs, suitable primers having Nde I and BamH I restriction sites were designed to amplify the IFNγ-cDNA by RT-PCR and the amplified h-IFNγ gene was cloned into the commercially available plasmid pRSET-A (Invitrogen). pNER41 was a generous gift from John Archer, Department of Genetics, Cambridge UK. It has a kanamycin resistance gene, a GFPmut3 reporter gene under the P lac promoter. The mut3 phenotype allows GFP to be expressed primarily as a soluble protein. The plasmid pGP1-2 has a kanamycin resistance gene, the origin of replication was taken from pACYC177 and it is used for the expression of the T7 RNA polymerase gene under the heat inducible λPL promoter .
Plasmid DNA from Corynebacterium renale was isolated by a modification of the alkaline lysis method  where the cells were initially incubated at 37°C for 2 hrs with 2 mg/ml lysozyme in Tris- glucose EDTA buffer. Plasmid DNA from E.coli was isolated by alkaline lysis method according to the standard procedure . Transformation was performed using an electroporator (Biorad Micropulser, USA). For this cells were grown in 100 ml LB to an OD600 of 0.6, chilled on ice and harvested by centrifugation (10 min, 4000 g at 4°C). The pellet was washed twice with 100 ml of distilled water and once with 10% glycerol. The washed pellet was resuspended in 5 ml of distilled water. Aliquots of 40 μl were mixed with 15 ng of plasmid DNA in chilled electroporation cuvettes (0.1 cm electrode gap). A pulse of 1.8 kV was applied and 1 ml SOC was immediately added. The culture was then revived for 2 hrs at 37°C before plating on antibiotic plates.
Plasmid copy number was determined according to the method of Seelke et.al . Typically plasmid DNA was extracted by alkaline lysis method from equal cell masses of overnight or exponentially growing cultures in antibiotic supplemented Luria broth. Equal amounts of plasmid- containing extract were then electrophoresed in agarose gels containing EtBr and plasmid bands were visualised under UV and quantitated by BIORAD Quantity One software.
Restriction enzymes, T4 DNA ligase and other DNA modifying enzymes purchased were from MBI Fermentas (GmbH) and New England Biolabs (USA). Cloning procedures, agarose gel electrophoresis and SDS-PAGE were performed according to standard procedures . DNA fragments were isolated from agarose gels by using the QIAquick gel extraction kit (QIAGEN). Primers were synthesised from Microsynth (Switzerland).
The primers used for amplification of ampicillin cassette were
(Forward primer) ampF: 5' CGT TTA TCG AT T CAG GTG GCA CTT TTC GG 3'
(Backward Primer) ampR: 5' CTT TTA TCG AT G GTC TGA CGC TCA GTG GA 3'
The underlined sequence represents Cla I recognition site.
The sequence of primers used for amplifying the T7-IFNγ expression cassette
Forward primer F: 5 'GAT ATG CAT CCC GCG AAA TTA AT 3'
Reverse primer R : 5' TAG AGG CCC CAA ATG CAT ATG CTA G 3'
The underlined sequence represents Nsi I recognition site.
Stability and compatibility studies
For studying stability a culture of E.coli DH5α cells containing the plasmid were grown in LB medium containing the appropriate antibiotic at 37°C from a single colony. An aliquot of 100 μl of this overnight culture was inoculated in 100 ml of fresh LB medium without antibiotic and grown for 24 hrs till the cells reached stationary phase. At this point the OD600 of the culture was typically between 2.0–2.4. The cfu/ml was calculated by counting the total number of colonies obtained after dilution plating which was found in the range of ~2 × 109 cells/ml. The fraction of non recombinants emerging in the culture was calculated by plating appropriate dilutions of this culture onto LB plates (without antibiotics) to get isolated colonies. More than 50 colonies were transferred onto LB antibiotic plates and the fraction of plasmid containing cells was calculated by counting the number of colonies which grew on the antibiotic plate. An aliquot (100 μl) of this stationary phase culture was used to inoculate 100 ml of fresh medium and this process of sub-culturing was repeated for six days. Since each inoculum was 0.1% (100 μl in 100 ml) it represented a 1000 fold increase in the cell number. This was also because both the OD and cfu/ml values were similar at the end of each sub-culturing. Thus every 24 hr period of growth would represent 10 doublings and hence 10 generations. For compatibility studies E.coli DH5α cells were co-transformed with two plasmids and the stability of both the plasmids was tested independently.
Expression of pCR2-IFNγ in shake flasks
For IPTG induced system E.coli BL21 (DE3) competent cells were transformed with pCR2-IFNγ. Primary culture was grown at 37°C at 200 rpm in 10 ml LB containing 100 μg/ml ampicillin. This culture was used to inoculate 100 ml of LB with antibiotic, allowed to grow till mid log phase (OD600 – 0.4 to 0.6) and induced by 1 mM IPTG. Samples were collected at 2 hour intervals for 8 hrs and analyzed on SDS-PAGE. For heat induced dual plasmid system E. coli DH5α cells were cotransformed with pCR2-IFNγ and pGP1-2 The cells harboring both the plasmids were grown in LB containing ampicillin (100 μg/ml) and kanamycin (50 μg/ml) to mid exponential phase at 30°C (thereby repressing the λPL promoter). The culture was induced by heat shock in a shaking water bath at 42°C for 5 min. The flask was then shifted to 37°C for further growth. Samples were collected at 2 hour intervals for 8 hrs and analyzed on SDS -PAGE. The stained gels were scanned using a Gel-Documentation system (Gel Doc™, Biorad) and analyzed using Quantity One Software (Biorad).
The proteins were separated on a 12.5% SDS-PAGE and transblotted onto a nitrocellulose (NC) membrane in a buffer containing 25 mM Tris HCl pH 8.3, 192 mM glycine and 20% methanol. After the transfer, the NC membranes were incubated in PBST (10 mM) containing 2% BSA for 90 minutes to block additional protein binding sites. After a brief wash with PBST, the membrane was incubated with anti-hIFNγ polyclonal antibodies (rabbit IgG, 1:10,000 dilution) for 1 hour at room temperature with gentle rocking. The membrane was then washed 3 times for 10 minutes in PBST and incubated in anti-rabbit IgG conjugated to Horse Radish Peroxidase (HRPO; 1:10,000 dilution)/alkaline phosphatase (AP; 1:10,000 dilution) at RT for 1 hours with gentle rocking. Finally, the membrane was washed 3 times for 10 minutes in PBST and the immunoreactive bands were visualized by 9 mg DAB and 20 μl H2O2 solution in 10 ml of 100 mM Tris HCl, pH 7.6, until the bands develop to the desired intensity.
Sustained expression capacity
To check the sustainability of expression over a large number of generations, the recombinant cells were grown in the absence of selection pressure with repeated sub-culturing as described previously in the segregation stability tests. Two flasks were used everyday, in which one of the flasks was induced at mid log phase, to study the production profile and the uninduced flask was used for sub-culturing after 24 hours of growth.
a) Sustained expression capacity of pCR2-IFNγ in heat inducible dual plasmid system
E. coli DH5α recombinant cells harbouring plasmids pCR2-IFNγ and pGP1-2 were grown overnight in LB containing ampicillin and kanamycin at 30°C and 200 rpm. 100 μl of this overnight culture was used to inoculate two flasks of 100 ml LB containing only kanamycin (50 μg/ml) to ensure the presence of pGP1-2 in the subsequent generations while eliminating the selection pressure on pCR2-IFNγ. One of the flasks was induced by heat shock (at OD600 0.4–0.6), transferred to 37°C and samples collected every two hours post induction for 8 hours. These samples were run on 12% SDS PAGE to check the level of IFNγ expression. The second flask was not induced and allowed to grow at 30°C for 24 hr thus representing 10 generations of uninduced growth. Sub-culturing was done by inoculating two flasks of LB (100 ml) as described previously. The expression levels were monitored consecutively for six days.
b) Sustained expression capacity of pCR2-P lac -GFP
E. coli DH5α cells harbouring pCR2-P lac -GFP plasmid were grown overnight in LB containing ampicillin at 37°C, 200 rpm. 100 μl of this overnight culture was used to inoculate two flasks of 100 ml LB without antibiotic. One of the flasks was induced by 1 mM IPTG when the cells were in mid exponential phase (OD600 0.4–0.6) and samples were collected every two hours post induction for 8 hrs. The bioactivity of GFP was measured by fluorescence by exciting the samples at 490 nm and reading the emission at 514 nm in a Cary Eclipse Fluorescence Spectrophotometer (Varian, Netherlands). The second flask was not induced and allowed to grow for 24 hr thus representing 10 generations of uninduced growth and used for subculturing. The production levels were monitored consecutively for six days.
Green fluorescent protein
Polymerase chain reaction
Sodium dodecyl sulphate- polyacrylamide gel electrophoresis.
Open reading frame
Multiple cloning site
Phosphate buffered saline tween
Horse Radish Peroxidase
- DAB 3:
We thank J. Archer and N. Ross for the gift of plasmid pNER41 and Pandey G. for plasmid pRSET-IFNγ. RW received a CSIR fellowship from the Govt of India.
- Bhattacharaya P, Pandey G, Srivastava P, Mukherjee KJ: Combined effect of protein fusion and signal sequence greatly enhances the production of recombinant GMCSF in E.coli. Mol Biotechnol. 2005, 30 (2): 103-116. 10.1385/MB:30:2:103.View ArticleGoogle Scholar
- Zavialov AV, Batchikova NV, Korpela T, Petrovskaya LE, Korobko VG, Kersley J, Macintyre S, Zavyalov VP: Secretion of recombinant proteins via the chaperone/usher pathway in E.coli. Appl Environ Microbiol. 2001, 67 (4): 1805-1814. 10.1128/AEM.67.4.1805-1814.2001.View ArticleGoogle Scholar
- Khushoo A, Pal Y, Singh BN, Mukherjee KJ: Extracellular expression and single step purification of recombinant Escherichia coli L-asparaginase II. Protein Expr Purif. 2004, 38: 29-36. 10.1016/j.pep.2004.07.009.View ArticleGoogle Scholar
- Friehs K: Plasmid copy number and plasmid stability. Adv Biochem Engg Biotechnol. 2004, 86: 47-82.Google Scholar
- Yazdani SS, Mukherjee KJ: Continuous culture studies on the stability and expression of recombinant streptokinase in Escherichia coli. Bioprocess Biosyst Engg. 2002, 24: 341-346. 10.1007/s004490100221.View ArticleGoogle Scholar
- Tolia NH, Tor LJ: Strategies of protein coexpression in Escherichia coli. Nat Methods. 2006, 3 (1): 55-61. 10.1038/nmeth0106-55.View ArticleGoogle Scholar
- Gupta JC, Jaisani M, Pandey G, Mukherjee KJ: Enhancing recombinant protein yields in Escherichia coli using the T7 system under the control of heat inducible lambda promoter. J Biotechnol. 1999, 68: 125-134. 10.1016/S0168-1656(98)00193-X.View ArticleGoogle Scholar
- Lan WS, Gu JD, Zhang JL, Shen BC, Jiang H, Mulchandani A, Chen W, Qiao CL: Co-expression of two detoxifying pesticide – degrading enzymes in a genetically engineered bacterium. Internat Biodeter Biodegrad. 2006, 58: 70-76. 10.1016/j.ibiod.2006.07.008.View ArticleGoogle Scholar
- Nishihara K, Kanemori M, Kitagawa M, Yanagi H, Yura T: Chaperone coexpression plasmids: differential and synergistic roles of DnaK-DnaJ-GrpE and GroEL-GroES in assisting folding of an allergen of Japanese cedar pollen, Cryj2, in Escherichia coli. Appl Environ Microbiol. 1998, 64 (5): 1694-1649.Google Scholar
- Olano C, Lomovskaya N, Fonstein L, Roll JT, Hutchinson CR: A two-plasmid system for the glycosylation of polyketide antibiotics: bioconversion of epsilon-rhodomycinone to rhodomycin D. Chem Biol. 1999, 6 (12): 845-855. 10.1016/S1074-5521(00)80004-6.View ArticleGoogle Scholar
- Liu CC, Schultz PG: Recombinant expression of selectively sulfated proteins in E.coli. Nat Biotech. 2006, 24 (11): 1436-1440. 10.1038/nbt1254.View ArticleGoogle Scholar
- Albrecht M, Misawa N, Sandmann G: Metabolic engineering of the terpenoid biosynthetic pathway of Escherichia coli for production of the carotenoids β-carotene and zeaxanthin. Biotech Lett. 1999, 21 (9): 791-795. 10.1023/A:1005547827380.View ArticleGoogle Scholar
- Riu L, Kwon YM, Reardon KF, Wood T: Metabolic pathway engineering to enhance aerobic degradation of chlorinated ethenes and to reduce their toxicity by cloning a novel glutathione S-transferase, an evolved toluene o-monooxygenase, and γ-glutamylcysteine synthetase. Environ Microbiol. 2004, 6 (5): 491-500. 10.1111/j.1462-2920.2004.00586.x.View ArticleGoogle Scholar
- Zhang H, Wu H, Zhang Hu: A novel high copy plasmid, pEC, compatible with commonly used Escherichia coli cloning and expression vectors. Biotech Lett. 2007, 29: 431-437. 10.1007/s10529-006-9258-5.View ArticleGoogle Scholar
- Sarovich DS, Pemberton JM: pPSX: A novel vector for the cloning and heterologous expression of antitumor antibiotic gene clusters. Plasmid. 2007Google Scholar
- Deb JK, Nath N: Plasmids of corynebacteria. FEMS Microbiol Lett. 1999, 175: 11-20. 10.1111/j.1574-6968.1999.tb13596.x.View ArticleGoogle Scholar
- Nath N: Molecular characterization of multiple plasmids of Corynebacterium renale. PhD Thesis. 1996, DBEB, Indian Institute of Technology, Delhi, IndiaGoogle Scholar
- Seelke R, Kline B, Aleff R, Porter RD, Shields MS: Mutations in the recD gene of Esherichia coli that raise the copy number of certain plasmids. J Bacteriol. 1987, 169: 4841-4844.Google Scholar
- Lenski RE, Bouma JE: Effect of segregation and selection on instability of plasmid pACYC184 in Escherichia coli. J Bacteriol. 1987, 169: 5314-5316.Google Scholar
- Pandey G: Kinetic studies for overproduction of human interferon gamma in E.coli and methylotropic yeast. PhD Thesis. 2003, School of Biotechnology, Jawaharlal Nehru University, Delhi, IndiaGoogle Scholar
- Zhelyabovskaya OB, Berlin YA, Birikh KR: Artificial genetic selection for an efficient translation initiation site for expression of human RACK1 gene in Escherichia coli. Nucl Acids Res. 2004, 32: e52-10.1093/nar/gnh050.View ArticleGoogle Scholar
- Tabor S, Richardson CC: A bacteriophage T7 RNA polymerase/promoter system for controlled exclusive expression of specific genes. Proc Natl Acad Sci. 1985, 82: 1074-1078. 10.1073/pnas.82.4.1074.View ArticleGoogle Scholar
- Sambrook J, Russell DW: Molecular cloning: A laboratory manual. Cold spring Harbor. 2001, Cold Spring harbor laboratory press, New York, 3Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.